Top

Published in:

01-12-2013 | Urology – Review

Lymph node dissection during radical cystectomy for bladder cancer treatment: considerations on relevance and extent

Authors: Lars Weisbach, Roland Dahlem, Giuseppe Simone, Jens Hansen, Armin Soave, Oliver Engel, Felix K. Chun, Shahrokh F. Shariat, Margit Fisch, Michael Rink

Published in: International Urology and Nephrology | Issue 6/2013

Abstract

Despite advances in the surgical and medical treatment for urothelial carcinoma of the bladder (UCB), there have only been limited improvements in disease-specific mortality rates over the past decades. Lymph node dissection (LND) during radical cystectomy is an integral part of the treatment for muscle-invasive and high-risk UCB. LND may detect and remove lymph node (LN) metastasis and thus guide patient counseling and decision making regarding additional treatment decisions. In addition, LND may improve survival in patients both with and without LN metastasis. In this non-systematic review article, we discuss benefits and risks of LND, the role of limited versus extended LND and the dilemma of preoperative LN staging.

Siegel R, Naishadham D, Jemal A (2013) Cancer Statistics 2013. CA Cancer J Clin 63(1):11–30PubMedCrossRef

Ferlay J, Shin HR et al (2010) Estimates of worldwide burden of cancer in 2008: globocan 2008. Int J Cancer 127:2893–2917PubMedCrossRef

Shariat SF, Palapattu GS, Amiel GE et al (2006) Outcomes of radical cystectomy for transitional cell carcinoma of the bladder: a contemporary series from the Bladder Cancer Research Consortium. J Urol 176(6 Pt 1):2414–2422PubMedCrossRef

Stein JP, Lieskovsky G, Cote R et al (2001) Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1,054 patients. J Clin Oncol 19:666–675PubMed

Madersbacher S et al (2003) Radical cystectomy for bladder cancer today—a homogeneous series without neoadjuvant therapy. J Clin Oncol 21(4):690–696PubMedCrossRef

Shariat SF, Rink M, Ehdaie B et al (2013) Pathological nodal staging score for bladder cancer: a decision tool for adjuvant therapy after radical cystectomy. Eur Urol 63:371–378PubMedCrossRef

Kassouf W, Svatek RS, Shariat SF et al (2013) Critical analysis and validation of lymph node density as prognostic variable in urothelial carcinoma of the bladder. Urol Oncol 31(4):480–486

Rink M, Hansen J, Cha E, Shariat SF et al (2013) Outcomes and prognostic factors in patients with a single lymph node metastasis at time of radical cystectomy. BJU Int 111(1):74–84PubMedCrossRef

Bruins HM, Huang GJ, Cai J, Skinner DG, Stein JP, Penson DF (2009) Clinical outcomes and recurrence predictors of lymph node positive urothelial cancer after cystectomy. J Urol 182:2182–2187PubMedCrossRef

10.

Herr HW, Bochner BH, Dalbagni G, Donat SM, Reuter VE, Bajorin DF (2002) Impact of the number of lymph nodes retrieved on outcome in patients with muscle invasive bladder cancer. J Urol 167:1295–1298PubMedCrossRef

11.

Karl A, Carroll PR, Gschwend JE et al (2009) The impact of lymphadenectomy and lymph node metastasis on the outcomes of radical cystectomy for bladder cancer. Eur Urol 55:826–835PubMedCrossRef

12.

Konety BR, Joslyn SA, O’ Donnell MA (2003) Extent of pelvic lymphadenectomy and its impact on outcome in patients diagnosed with bladder cancer: analysis of data from the Surveillance, epidemiology and end results program data base. J Urol 169:946–950PubMedCrossRef

13.

Mills RD, Turner WH, Fleischmann A, Markwalder R, Thalmann GN, Studer UE (2001) Pelvic lymph node metastases from bladder cancer: outcome in 83 patients after radical cystectomy and pelvic lymphadenectomy. J Urol 166:19–23PubMedCrossRef

14.

Stein JP, Cai J, Groshen S, Skinner DG (2003) Risk factors for patients with pelvic lymph node metastases following radical cystectomy with en bloc pelvic lymphadenectomy: concept of lymph node density. J Urol 170:35–41PubMedCrossRef

15.

Vieweg J, Gschwend JE, Herr HW, Fair WR (1999) The impact of primary stage on survival in patients with lymph node positive bladder cancer. J Urol 161:72–76PubMedCrossRef

16.

Stenzl A, Cowan NC, De Santis M, Jakse G, Kuczyk MA, Merseburger AS, Ribal MJ, Sherif A, Witjes JA (2010) European Association of Urology. Update of the clinical guidelines of the European Association of Urology on muscle invasive and metastatic bladder carcinoma. Actas Urol Esp 34:51–62PubMedCrossRef

17.

Shariat SF, Palapattu GS, Karakiewicz PI et al (2007) Discrepancy between clinical and pathological stage: impact on prognosis after radical cystectomy. Eur Urol 51:137–151PubMedCrossRef

18.

Cowan NC, Crew JP (2010) Imaging bladder cancer. Curr Opin Urol 20:409–413PubMedCrossRef

19.

Sherif A, Garske U, de la Torre M, Thörn M (2006) Hybrid SPECT-CT:an additional technique for sentinel node detection of patients with invasive bladder cancer. Eur Urol 50:83–91PubMedCrossRef

20.

Liedberg F, Chebil G, Davidsson T, Gudjonnson S, Mansson W (2006) Intraoperative sentinel node detection improves nodal staging in invasive bladder cancer. J Urol 175:84–88PubMedCrossRef

21.

Machtens S, Serth J, Meyer A, Kleinhorst C, Ommer KJ, Herbst U, Kieruij M, Boerner AR (2007) Positron emission tomography (PET) in the urooncological evaluation of the small pelvis. World J Urol 4:341–349CrossRef

22.

Bellin MF, Roy C (2007) Magnetic resonance lymphography. Curr Opin Urol 17:65–69PubMedCrossRef

23.

Stenzl A, Cowan NC, De Santis M et al (2011) Treatment of muscle invasive and metastatic bladder cancer: update of the EAU Guidelines. Eur J Urol 59:1009–1018CrossRef

24.

Skinner DG (1982) Management of invasive bladder cancer: a meticulous pelvic node dissection can make a difference. J Urol 128:34–36PubMed

25.

Dorin RP, Skinner EC (2010) Extended lymphadenectomy in bladder cancer. Curr Opin Urol 20:414–420PubMedCrossRef

26.

Stein JP (2007) The role of lymphadenectomy in patients undergoing radical cystectomy for bladder cancer. Curr Oncol Rep 9:213–221PubMedCrossRef

27.

Stein JP, Skinner DG (2004) Surgical atlas radical cystectomy. BJU Int 94:97–121CrossRef

28.

Roth B, Wissmayer MP, Zehnder P et al (2010) A new multimodality technique accurately maps the primary lymphatic landing sites of the bladder. Eur Urol 57:205–211PubMedCrossRef

29.

Vazina A, Dugi D, Shariat SF, Evans J, Link R, Lerner R, Lerner SP (2004) Stage specific lymph node metastasis mapping in radical cystectomy specimen. J Urol 171:1830–1834PubMedCrossRef

30.

Abol-Enein H, El-Baz M, Abd-El-Hameed MA, Abdel-Latif M, Ghonheim MA (2004) Lymph node involvement in patients with bladder cancer treated with radical cystectomy: a patho-anatomical study—a single center experience. J Urol 172:1818–1821PubMedCrossRef

31.

Leissner J, Ghoneim MA, Abol-Enein H et al (2004) Extended radical lymphadenectomy in patients with urothelial bladder cancer: results of a prospective multicenter study. J Urol 171:139–144PubMedCrossRef

32.

Seiler R, von Gunten M, Thlmann GN, Fleischmann A (2010) Pelvic lymph nodes: distribution and nodal tumour burden of urothelial bladder cancer. J Clin Pathol 63:504–507PubMedCrossRef

33.

Dorin RP, Daneshmand S, Skinner EC et al (2011) Lymph node dissection technique is more important than lymph node count in identifying nodal metastases in radical cystectomy patients: a comparative mapping study. Eur Urol 60:946–952PubMedCrossRef

34.

Rink M, Cha EK, Green D, Shariat SF et al (2012) Biomolecular Predictors of Urothelial Cancer Behavior and Treatment Outcomes. Curr Urol Rep 13(2):122–135PubMedCrossRef

35.

Burkhard FC, Roth B, Zehnder P, Studer UE (2011) Lymphadenectomy for bladder cancer: indications and controversies. Urol Clin North Am 38(4):397–405PubMedCrossRef

36.

Lerner SP, Skinner DG, Lieskovsky G et al (1993) The rationale for en bloc pelvic lymph node dissection for bladder cancer patients with nodal metastases: long term results. J Urol 149:758–765PubMed

37.

Vieweg J, Whitmore WF Jr, Herr HW et al (1994) The role of pelvic lymphadenectomy and radical cystectomy for lymph node positive bladder cancer. The Memorial Sloan Kettering Cancer Center experience. Cancer 73:3020–3028PubMedCrossRef

38.

May M, Herrmann E, Bolenz C et al (2011) Association between the number of dissected lymph nodes during pelvic lymphadenectomy and cancer-specific survival in patients with lymph node-negative urothelial carcinoma of the bladder undergoing radical cystectomy. Ann Surg Oncol 18:2018–2025PubMedCrossRef

39.

Herr HW, Faulkner JR, Grossmann HB et al (2004) Surgical factors influence bladder cancer outcomes: a cooperative group report. J Clin Oncol 22(14):2781–2789PubMedCrossRef

40.

Leissner J, Hohenfellner R, Thuroff JW, Wolf HK (2000) Lymphadenectomy in patients with transitional cell carcinoma of the urinary bladder; significance for staging and prognosis. BJU Int 85:817–823PubMedCrossRef

41.

Simone G, Papalia R, Ferriero M, Guaglianone S, Castelli E, Collura D, Muto G, Gallucci M (2012) Stage specific impact of extended versus standard pelvic lymph node dissection in radical cystectomy. Int J Urol 20(4):1442–2042

42.

Dhar NB, Klein EA, Reuther AM, Thalmann GN, Madersbacher S, Studer UE (2008) Outcome after radical cystectomy with limited or extended pelvic lymph node dissection. J Urol 179:873–878PubMedCrossRef

43.

Rink M, Shariat SF, Xylinas E (2012) Does increasing the nodal yield improve outcomes in patients without nodal metastasis at radical cystectomy? World J Urol 30(6):807–814PubMedCrossRef

44.

Tarin TV, Power NE, Bochner BH et al (2012) Lymph node-positive bladder cancer treated with radical cystectomy and lymphadenectomy: effect of the level of node positivity. Eur Urol 61:1025–1030PubMedCrossRef

45.

Kurahashi T, Hara I, Oka N, Kamidono S, Eto H, Miyake H (2005) Detection of micrometastases in pelvic lymph nodes in patients undergoing radical cystectomy for locally invasive bladder cancer by real-time reverse transcriptase-PCR for cytokeratin 19 and uroplakin II. Clin Cancer Res 11(10):3773–3777PubMedCrossRef

46.

Morgan T, Kaffenberger S, Cookson M (2012) Surgical and chemotherapeutic management of regional lymph nodes in bladder cancer. J Urol 188:1081–1088PubMedCrossRef

47.

May M, Herrmann E, Bolenz C, Bastian PJ et al (2011) Lymph node density affects cancer-specific survival in patients with lymph node-positive urothelial bladder cancer following radical cystectomy. Eur Urol 59(5):712–718PubMedCrossRef

48.

Stein JP, Penson DF, Cai J et al (2007) Radical cystectomy with extended lymphadenectomy: evaluating separate package versus en bloc submission for node positive bladder cancer. J Urol 177:876–881PubMedCrossRef

49.

Shariat SF, Ehdaie B, Rink M et al (2012) Clinical nodal staging scores for bladder cancer: a proposal for preoperative risk assessment. Eur Urol 61(2):237–242PubMedCrossRef

50.

Koppie TM, Vickers AJ, Vora K, Dalbagni G, Bochner BH (2006) Standardization of pelvic lymphadenectomy performed at radical cystectomy: can we establish a minimum number of lymph nodes that should be removed? Cancer 107(10):2368–2374PubMedCrossRef

51.

Karakiewicz PI, Shariat SF, Palapattu GS et al (2006) Nomogram for predicting disease recurrence after radical cystectomy for transitional cell carcinoma of the bladder. J Urol 176:1354–1362PubMedCrossRef

52.

Shariat SF, Karakiewicz PI, Palapattu GS et al (2006) Nomograms provide improved accuracy for predicting survival after radical cystectomy. Clin Cancer Res 12:6663–6676PubMedCrossRef

53.

Brossner C, Pycha A, Toth A, Mian C, Kuber W (2004) Does extended pelvic lymphadenectomy increase the morbidity of radical cystectomy? BJU Int 93:64–66PubMedCrossRef

54.

Rink M, Chun FK, Shariat SF et al (2012) Advanced bladder cancer in elderly patients. Prognostic outcomes and therapeutic strategies. Urologe A 51(6):820–828PubMedCrossRef

55.

Capitanio U, Suardi N, Shariat SF et al (2009) Assessing the minimum number of lymph nodes needed at radical cystectomy in patients with bladder cancer. BJU Int 103:1359–1362PubMedCrossRef

Title: Lymph node dissection during radical cystectomy for bladder cancer treatment: considerations on relevance and extent
Authors: Lars Weisbach
Roland Dahlem
Giuseppe Simone
Jens Hansen
Armin Soave
Oliver Engel
Felix K. Chun
Shahrokh F. Shariat
Margit Fisch
Michael Rink
Publication date: 01-12-2013
Publisher: Springer Netherlands
Published in: International Urology and Nephrology / Issue 6/2013
Print ISSN: 0301-1623
Electronic ISSN: 1573-2584
DOI: https://doi.org/10.1007/s11255-013-0503-2

ACC 2024 Congress Coverage

Heart Failure Video

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Lymph node dissection during radical cystectomy for bladder cancer treatment: considerations on relevance and extent

Abstract

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 6/2013

Influence of hemodialysis on incretin hormones and insulin secretion in diabetic and non-diabetic patients

The risk of atherosclerosis in patients with chronic kidney disease

Peripheral Treg count and it’s determinants in unsensitized and sensitized chronic kidney disease patients

Sexual dysfunction predicts depression among women on hemodialysis

Increased basal nitric oxide amplifies the association of inflammation with all-cause and cardiovascular mortality in prevalent hemodialysis patients

The role of therapeutic drug monitoring in the treatment of cytomegalovirus disease in kidney transplantation

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page